Screener

Eligibility screening

Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors

Sponsored by Merck Sharp & Dohme LLCStudy detailsClinicalTrials.gov

17 US sites in CA, CO, CT, FL +12

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.